Tanzina Haque

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, Joe Grove, Oscar A. MacLean et al. · Nature Microbiology · 2022 · 701 citations · Full text

Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

Tanzina Haque, Gwen Wilkie, Marie M. Jones et al. · Blood · 2007 · 637 citations

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 446 citations · Full text

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Paul Griffiths, Anna Stanton, Erin McCarrell et al. · The Lancet · 2011 · 390 citations · Full text

Vaccination, Mf59 Adjuvant, Transplantation +10

Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

Tanzina Haque, Gwen Wilkie, Clare Taylor et al. · The Lancet · 2002 · 363 citations

Cell Therapy, Transplantation, Immunology +9